Hanjoon Alex Kim - Apr 4, 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
Chief Operating Officer
Signature
/s/ Hanjoon Alex Kim by Nicholas Khadder, Attorney-in-Fact
Stock symbol
LAB
Transactions as of
Apr 4, 2022
Transactions value $
$0
Form type
4
Date filed
4/6/2022, 06:35 PM
Next filing
Apr 6, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Restricted Stock Units Award $0 +281K $0.00 281K Apr 4, 2022 Common Stock 281K Direct F1, F2
transaction LAB Stock Option (Right to Buy) Award $0 +1.62M $0.00 1.62M Apr 4, 2022 Common Stock 1.62M $3.99 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.
F2 Restricted Stock Units vest in four equal annual installments beginning April 4, 2023.
F3 The Option becomes exercisable as to 1/4th of the underlying shares on April 4, 2023, and as to an additional 1/48th of the total number of shares each month thereafter.